RE-BVS – Piemonte Repository

Sfoglia per AUTORE
STELITANO C
Collezione AO Cuneo

Items : 6

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...

Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Mar 1;40(7):729-739. doi: 10.1200/JCO.21.01234. Epub 2021 Oct 28.

2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Anastasia A; Dondi A; Mannina D; Federico M; Zilioli VR; Merli A; Ladetto M; Bolis S; Pavone V; Chiarenza A; Arcari A; Ricci F; Pinto A; Margiotta Casaluci G; Patti C; Stelitano C; Skrypets T; Del Giudice I; Chauvie S; Kovalchuk S; Ferrero S; Arcaini L; Cavallo F; Guerra L; Marcheselli L; Olivieri J; Tucci A; Boccomini C; Farina L; et alii...

Relapsing/refractory HL after autotransplantation: which treatment? in Acta bio-medica : Atenei Parmensis / Acta Biomed. 2020 May 25;91(S-5):30-40. doi: 10.23750/abm.v91iS-5.9912.

2020
AO Cuneo

Di Renzo N; Gaudio F; Carlo Stella C; Oppi S; Pelosini M; Sorasio R; Stelitano C; Rigacci L;

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses. in British journal of haematology / Br J Haematol. 2011 Mar;152(5):551-60. doi: 10.1111/j.1365-2141.2010.08485.x. Epub 2010 Dec 20.

2011
AO Cuneo

Gallamini A; Patti C; Viviani S; Rossi A; Fiore F; Di Raimondo F; Cantonetti M; Stelitano C; Feldman T; Gavarotti P; Sorasio R; Mulè A; Leone M; Rambaldi A; Biggi A; Barrington S; Fallanca F; Ficola U; Chauvie S; Gianni AM;

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. in Haematologica / Haematologica. 2006 Apr;91(4):475-81.

2006
AO Cuneo

Gallamini A; Rigacci L; Merli F; Nassi L; Bosi A; Capodanno I; Luminari S; Vitolo U; Sancetta R; Iannitto E; Trentin L; Stelitano C; Tavera S; Biggi A; Castagnoli A; Versari A; Gregianin M; Pelosi E; Torchio P; Levis A;

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. in Blood / Blood. 2004 Apr 1;103(7):2474-9. doi: 10.1182/blood-2003-09-3080. Epub 2003 Nov 26.

2004
AO Cuneo

Gallamini A; Stelitano C; Calvi R; Bellei M; Mattei D; Vitolo U; Morabito F; Martelli M; Brusamolino E; Iannitto E; Zaja F; Cortelazzo S; Rigacci L; Devizzi L; Todeschini G; Santini G; Brugiatelli M; Federico M;